TAIWAN · TWSE / TPEx
Maywufa
美吾華 · 1731 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$20.951 month +1.0% · 1 year +1.8%
Directors and supervisors hold42,221,75631.8% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold58,881,45644.3% of shares issued
Revenue, 2026-09+9.7%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 誠意投資股份有限公司 | Chairman · Vice chairman · Director · Major shareholder (10%+) | 23,594,819 | 23,594,819 | 17.75% | — | — |
| 李成家 | Chairman (corporate representative) | — | 2,697,451 | 2.03% | — | — |
| 李伊俐 | Vice chairman (corporate representative) | — | 1,392,000 | 1.05% | — | — |
| 力領投資股份有限公司 | Director · Major shareholder (10%+) | 14,946,556 | 18,548,937 | 13.96% | — | — |
| 李伊伶 | Director (corporate representative) | — | 140,000 | 0.11% | — | — |
| 賴育儒 | Director (corporate representative) · President | — | 205,000 | 0.15% | — | — |
| 李碧珍 | Director (corporate representative) | — | 239,000 | 0.18% | — | — |
| 李育家 | Director (corporate representative) | — | 104,500 | 0.08% | — | 10,000 |
| 于昌民 | Director (corporate representative) · Vice president | — | 10,000 | 0.01% | — | — |
| 華蔚有限公司 | Director | 78,000 | 78,000 | 0.06% | — | — |
| 劉文正 | Director (corporate representative) | — | 0 | — | — | — |
| 賴淑子 | Director (corporate representative) | — | 0 | — | — | — |
| 陳慧遊 | Independent director | — | 0 | — | — | — |
| 歐淑芳 | Independent director | — | 0 | — | — | — |
| 張鴻仁 | Independent director | — | 0 | — | — | — |
| 林峰 | Independent director | — | 0 | — | — | — |
| 林合辰 | Assistant vice president | — | 0 | — | — | — |
| 懷特生技新藥股份有限公司 | Major shareholder (10%+) | — | 16,737,700 | 12.59% | — | — |
| 陳昭明 | Chief financial officer · Chief accountant | — | 0 | — | — | — |